Financials

  • Market Capitalization 33.69 B
  • Employee 11 K
  • Founded 1999
  • CEO Kevin R. Sayer
  • Website www.dexcom.com
  • Headquarter Delaware, United States
  • FIGI BBG000QTF8K1
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
31.76
Price to sales ratio
5.77

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
314
EW
Edwards Lifesciences Corporation Common Stock
89.95 USD-0.90%+0.13%+6.35%+10.73%51.85 B USD
349
MDLN
Medline Inc. - Class A common stock
34.65 USD+0.20%+6.58%-14.19%-1.00%45.55 B USD
494
PHG
Koninklijke Philips N.V. NY Registry Shares
26.93 USD-0.26%-1.46%+5.24%-7.62%26.89 B USD
562
STE
STERIS plc Ordinary Shares
232.82 USD-1.73%-1.69%+0.98%-4.90%22.70 B USD

Frequently asked questions about DexCom, Inc.

What is the DexCom, Inc. stock price today?

The current price of DexCom, Inc. (DXCM) is 89.29. Over the past 24 hours, the stock has changed by +0.37%. Follow the DXCM chart for real-time price dynamics.

What is the stock ticker of DexCom, Inc.?

DexCom, Inc. trades under the ticker DXCM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is DexCom, Inc. stock going up?

DXCM has changed by -0.36% over the last week, +19.98% over the last month, and +18.93% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of DexCom, Inc.?

DexCom, Inc. currently has a market capitalization of 33.69 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were DexCom, Inc. earnings last quarter?

Last quarter, DexCom, Inc. reported earnings of 0.65 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was DexCom, Inc. revenue for the last quarter?

DexCom, Inc. reported quarterly revenue of 1.31 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was DexCom, Inc. net income for the last quarter?

DexCom, Inc. reported net income of 249.1 M for the last quarter. The previous quarter showed 199.5 M, which means net income changed by +24.86%.

How many employees does DexCom, Inc. have?

As of the latest available data, DexCom, Inc. has 11.1 K employees. Workforce size can provide additional context about the company's scale and operations.

What is DexCom, Inc. EBITDA?

DexCom, Inc. EBITDA is 386.5 M, and its EBITDA margin is 29.54%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy DexCom, Inc. stock?

You can buy DexCom, Inc. (DXCM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in DexCom, Inc. stock?

Investing in DexCom, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DXCM chart and related analysis on metatrader.com as part of your research.

DexCom, Inc. - Common Stock

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.

News